Goran Pharma Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 03-07-2024
- Paid Up Capital ₹ 0.06 Cr
as on 03-07-2024
- Company Age 32 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
as on 03-07-2024
- Satisfied Charges ₹ 0.18 Cr
as on 03-07-2024
- Revenue 12.82%
(FY 2022)
- Profit 40.47%
(FY 2022)
- Ebitda -23.98%
(FY 2022)
- Net Worth 15.20%
(FY 2022)
- Total Assets 19.03%
(FY 2022)
About Goran Pharma
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.06 Cr.
The company currently has active open charges totaling ₹2.00 Cr. The company has closed loans amounting to ₹1.79 M, as per Ministry of Corporate Affairs (MCA) records.
Sheetal Dholakia, Anand Sheth, Chandrakant Parikh, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24231GJ1992PTC017069
- Company No.
017069
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Feb 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Bhavnagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Goran Pharma Pvt Ltd offer?
Goran Pharma Pvt Ltd offers a wide range of products and services, including Common Disease Medicines, Antiseptic Mouthwashes, Hand Sanitizers & Personal Hygiene, Toothpastes, Ointment.
Who are the key members and board of directors at Goran Pharma?
Board Members(6)
Financial Performance and Corporate Structure Insights of Goran Pharma.
Goran Pharma Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 12.82% increase. The company also saw a substantial improvement in profitability, with a 40.47% increase in profit. The company's net worth Soared by an impressive increase of 15.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Goran Pharma?
In 2020, Goran Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hansrx Private Limited
Active
29 years 11 months Anand Sheth, Chandrakant Parikh and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 18 Jan 2018 | ₹2.00 Cr | Open |
Idbi Bank Ltd. Creation Date: 09 Mar 2013 | ₹1.71 M | Satisfied |
State Bank Of Saurashtra Creation Date: 11 Mar 1994 | ₹0.08 M | Satisfied |
How Many Employees Work at Goran Pharma?
Goran Pharma has a workforce of 78 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Goran Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Goran Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
